Tretinoin Patent Expiration
Tretinoin was first introduced by Valeant International Barbados Srl
Tretinoin Patents
Given below is the list of patents protecting Tretinoin, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Altreno | US10653656 | Topical pharmaceutical compositions for treating skin conditions | Aug 22, 2038 | Dow Pharm |
Altreno | US11324710 | Topical pharmaceutical compositions for treating skin conditions | Aug 22, 2038 | Dow Pharm |
Altreno | US6517847 | Topical gel delivery system |
Aug 03, 2020
(Expired) | Dow Pharm |
Renova | US6531141 | Oil-in-water emulsion containing tretinoin |
Mar 07, 2020
(Expired) | Valeant Pharms North |
Retin-a Micro | US5955109 | Methods and compositions for topical delivery of retinoic acid |
Sep 21, 2016
(Expired) | Bausch |
Retin-a-micro | US5955109 | Methods and compositions for topical delivery of retinoic acid |
Sep 21, 2016
(Expired) | Bausch |
Atralin | US5670547 | Moisturizing vehicle for topical application of vitamin A acid |
Sep 23, 2014
(Expired) | Dow Pharm |
Tretinoin's Family Patents

Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List